Digene Corp., a Gaithersburg-based maker of diagnostic tests, announced yesterday the termination of its merger with Cytyc Corp. The decision was widely expected after the Federal Trade Commission ...

Digene Corp. of Gaithersburg will pay a New York biotechnology company at least $30.5 million to settle a patent-infringement lawsuit involving technology used in its leading product, the only ...

Facing increased competition for its main product – the HPV Test – and questions about its plans for growth, Gaithersburg’s Digene Corp. agreed yesterday to be acquired by a foreign company in a $1.6 ...

Shares of Digene, a maker of DNA and RNA tests, sizzled on Monday after it announced that Netherlands-based Qiagen would purchase the company in a $1.6 billion deal. Digene is best known for a test to ...

Deal consolidates firms’ technology in molecular diagnostics. Qiagen and Digene entered into a definitive agreement to combine the two companies to create market and technology leadership in molecular ...

QIAGEN N.V. and Digene Corp. have announced a definitive agreement to combine the two companies to create market- and technology-leadership in molecular diagnostics. The Boards of Directors of both ...

The Gaithersburg company that makes the only approved test for the virus that causes cervical cancer is taking its message out of doctors’ offices and into homes nationwide. Digene Corp. is launching ...

The name of Joe Simons, director of the Federal Trade Commission's Bureau of Competition, was misspelled in a June 25 Business article. (Published 6/26/02) The Federal Trade Commission voted ...

The Daily Record is a digital-first daily news media company focused on law, government, business, recognition events, Power Lists, special products, public notices and more.